Eli Lilly and Co
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 43K
- Market Cap
- $859.4B
- Introduction
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol
- Conditions
- Hyperlipidemia
- Interventions
- Drug: Placebo SCDrug: LY3015014 IVDrug: Placebo IVDrug: LY3015014 SC
- First Posted Date
- 2011-08-31
- Last Posted Date
- 2019-04-05
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 69
- Registration Number
- NCT01426412
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison, Wisconsin, United States
A Study in Adults With Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2014-12-18
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 759
- Registration Number
- NCT01421459
- Locations
- 🇨🇳
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Yong Kung City, Taiwan
A Study in Adults With Type 1 Diabetes
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2014-10-09
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 536
- Registration Number
- NCT01421147
- Locations
- 🇷🇴
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Timisoara, Romania
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
- Conditions
- HypogonadismEjaculatory Dysfunction
- Interventions
- Drug: Testosterone Solution 2%Drug: Placebo Solution
- First Posted Date
- 2011-08-18
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 76
- Registration Number
- NCT01419236
- Locations
- 🇨🇦
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Quebec City, Quebec, Canada
A Study of LY2523355 in Participants With Breast Cancer
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2019-09-18
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 39
- Registration Number
- NCT01416389
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Richmond, Virginia, United States
A Study in Patients With Type 2 Diabetes
- First Posted Date
- 2011-08-03
- Last Posted Date
- 2011-08-25
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 240
- Registration Number
- NCT01408095
- Locations
- 🇪🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sevilla, Spain
A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Biological: LY2189265Drug: Sitagliptin
- First Posted Date
- 2011-08-03
- Last Posted Date
- 2014-10-07
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 29
- Registration Number
- NCT01408888
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas, Texas, United States
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 4299
- Registration Number
- NCT01400971
- Locations
- 🇬🇧
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chesterfield, United Kingdom
A Bioavailability Study of LY2452473 and Tadalafil
- Conditions
- Erectile Dysfunction
- Interventions
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2019-06-14
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 24
- Registration Number
- NCT01401543
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison, Wisconsin, United States
A Relative Bioavailability and Food Effect Study of New Formulations
- Conditions
- Chronic Inflammatory DisorderArthritis, Rheumatoid
- Interventions
- Drug: LY3009104
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 15
- Registration Number
- NCT01398475
- Locations
- 🇸🇬
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore, Singapore